Occult Hepatitis B (OBH) in Clinical Settings

被引:19
作者
Alavian, Seyed Moayed [2 ]
Miri, Seyed Mohammad [2 ]
Hollinger, F. Blaine [3 ]
Jazayeri, Seyed Mohammad [1 ]
机构
[1] Univ Tehran Med Sci, Sch Publ Hlth, Dept Virol, Tehran, Iran
[2] Baqiyatallah Univ Med Sci, Baqiyatallah Res Ctr Gastroenterol & Liver Dis, Tehran, Iran
[3] Baylor Coll Med, Houston, TX 77030 USA
关键词
Hepatitis B; Hepatitis B Surface Antigens; Coinfection; HIV-INFECTED PATIENTS; HBSAG-NEGATIVE PATIENTS; C HEPATOCELLULAR-CARCINOMA; ANTIBODY-POSITIVE DONORS; VIRUS HBV INFECTION; LIVER-TRANSPLANTATION; SURFACE-ANTIGEN; BLOOD-DONORS; CORE ANTIGEN; HIGH PREVALENCE;
D O I
10.5812/hepatmon.6126
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Context: Occult hepatitis B (OHB), or persistent HBV DNA in patients who are hepatitis B surface antigen (HBsAg) negative, is a recently recognized entity. In an attempt to summarize the issues, this review presents an overview of the current proposed hypothesis on the clinical relevance and also updates the knowledge on the classification of OHB in different clinical settings. Evidence Acquisition: OHB could be found in different population and clinical backgrounds including: viral co-infections (with either human immunodeficiency or hepatitis C viruses), HBV chronic carriers, dialysis patients, transplantation settings and certain clinical situations (named in here: special clinical settings) with no apparent distinguishable clinical parameters. Results: The exact magnitude, pathogenesis, and clinical relevance of OHB are unclear. Even the possible role exerted by this cryptic infection on liver disease outcome, and hepatocellular carcinoma development remains unknown. Conclusions: monitoring of Individuals with positive anti-HBc, mass immunization programs and improvement in diagnostic tools seem to be important to control the probability of transmission of HBV through cryptic HBV infection. Published by Kowsar Corp, 2012. cc 3.0.
引用
收藏
页数:8
相关论文
共 104 条
[1]  
Al-Mahtab M, 2008, HEPAT MON, V8, P147
[2]   Other views of occult hepatitis B in Hepatitis C infected patients [J].
Alavian, Seyed Moayed ;
Jazayeri, Seyed Mohammad .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2011, 22 (05) :E67-E68
[3]  
Alavian SM, 2003, AM J GASTROENTEROL, V98, P937
[4]   Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion [J].
Allain, JP ;
Hewitt, PE ;
Tedder, RS ;
Williamson, LM .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (01) :186-195
[5]   Hepatitis B and liver transplantation [J].
Angus, PW .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 12 (03) :217-223
[6]   Antiretroviral therapy and HIV/hepatitis B virus coinfection [J].
Benhamou, Y .
CLINICAL INFECTIOUS DISEASES, 2004, 38 :S98-S103
[7]   Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice [J].
Bhatti, Farhat Abbas ;
Ullah, Zia ;
Salamat, Nuzhat ;
Ayub, Muhammad ;
Ghani, Ejaz .
TRANSFUSION, 2007, 47 (01) :74-79
[8]   Impact of HBV HCV and GBV-C/HGV on hepatocellular carcinomas in Europe:: results of a European concerted action [J].
Bréchot, C ;
Jaffredo, F ;
Lagorce, D ;
Gerken, G ;
zum Büschenfelde, KM ;
Papakonstontinou, A ;
Hadziyannis, S ;
Romeo, R ;
Colombo, M ;
Rodes, J ;
Bruix, J ;
Williams, R ;
Naoumov, N .
JOURNAL OF HEPATOLOGY, 1998, 29 (02) :173-183
[9]   Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen:: Clinically significant or purely "occult"? [J].
Bréchot, C ;
Thiers, V ;
Kremsdorf, D ;
Nalpas, B ;
Pol, S ;
Paterlini-Bréchot, P .
HEPATOLOGY, 2001, 34 (01) :194-203
[10]   Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease [J].
Cacciola, I ;
Pollicino, T ;
Squadrito, G ;
Cerenzia, G ;
Orlando, ME ;
Raimondo, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (01) :22-26